当前位置:首页 - 行情中心 - 金河生物(002688) - 财务分析 - 利润表

金河生物

(002688)

  

流通市值:44.02亿  总市值:44.79亿
流通股本:6.24亿   总股本:6.35亿

利润表

按照会计年度查询:
报告期2021-03-312020-12-312020-09-302020-06-30
一、营业总收入462,170,158.211,814,638,965.541,207,063,049.96848,429,942.59
营业收入462,170,158.211,814,638,965.541,207,063,049.96848,429,942.59
二、营业总成本387,024,336.771,688,685,472.761,087,562,610.77732,854,829.51
营业成本273,188,824.151,184,690,818.5731,512,175.18529,739,916.17
营业税金及附加4,521,401.7817,147,567.313,540,397.039,493,165.75
销售费用31,614,336.1113,209,708.96101,855,569.1464,498,441.38
管理费用47,540,372.75222,352,486.18140,255,773.4578,975,896.54
财务费用12,788,657.384,926,864.253,403,942.2718,302,920.22
资产减值损失778,884.38-12,846,833.18-515,842.58-117,921.33
三、其他经营收益2,642,538.61-27,298,756.62-10,125,201.216,378,065.41
允许价值变动净收益--------
投资净收益--------
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润81,325,880.73129,433,088.4131,225,499.93122,847,979.29
营业外收入21,565,147.8318,924,949.66931,378.42800,232.87
营业外支出6,764.737,452,628.871,194,460.41,048,920.74
非流动资产处置净损失--------
五、利润总额102,884,263.83140,905,409.19130,962,417.95122,599,291.42
所得税6,667,660.741,712,337.2712,723,884.4615,468,651.22
未确认的投资损失--------
六、净利润(百万元)85.43117.32101.9495.01
少数股东损益10,790,768.7521,868,545.9916,301,483.3112,125,191.4
归属于母公司股东的净利润85,425,834.34117,324,525.93101,937,050.1895,005,448.8
七、每股收益0.130.180.160.15
基本每股收益0.130.180.160.15
稀释每股收益0.130.180.160.15
TOP↑